StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
UBS Reiterates Sell Rating on GlaxoSmithKline (GSK:LN) (GSK)
December 7, 2022 4:24 AM
UBS analyst (Michael Leuchten ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Intl Ratings